188 related articles for article (PubMed ID: 35697535)
1. ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer.
Nakamura K; Shigeyasu K; Okamoto K; Matsuoka H; Masuyama H
Gynecol Oncol; 2022 Aug; 166(2):326-333. PubMed ID: 35697535
[TBL] [Abstract][Full Text] [Related]
2. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
[TBL] [Abstract][Full Text] [Related]
3. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
Takeda S; Shigeyasu K; Okugawa Y; Yoshida K; Mori Y; Yano S; Noma K; Umeda Y; Kondo Y; Kishimoto H; Teraishi F; Nagasaka T; Tazawa H; Kagawa S; Fujiwara T; Goel A
Cancer Lett; 2019 Mar; 444():127-135. PubMed ID: 30583079
[TBL] [Abstract][Full Text] [Related]
4. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.
Shigeyasu K; Okugawa Y; Toden S; Miyoshi J; Toiyama Y; Nagasaka T; Takahashi N; Kusunoki M; Takayama T; Yamada Y; Fujiwara T; Chen L; Goel A
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925690
[TBL] [Abstract][Full Text] [Related]
5. RNA editing of AZIN1 coding sites is catalyzed by ADAR1 p150 after splicing.
Xing Y; Nakahama T; Wu Y; Inoue M; Kim JI; Todo H; Shibuya T; Kato Y; Kawahara Y
J Biol Chem; 2023 Jul; 299(7):104840. PubMed ID: 37209819
[TBL] [Abstract][Full Text] [Related]
6. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
[TBL] [Abstract][Full Text] [Related]
7. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
8. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.
Chen L; Li Y; Lin CH; Chan TH; Chow RK; Song Y; Liu M; Yuan YF; Fu L; Kong KL; Qi L; Li Y; Zhang N; Tong AH; Kwong DL; Man K; Lo CM; Lok S; Tenen DG; Guan XY
Nat Med; 2013 Feb; 19(2):209-16. PubMed ID: 23291631
[TBL] [Abstract][Full Text] [Related]
9. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P
Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
[TBL] [Abstract][Full Text] [Related]
10. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
[TBL] [Abstract][Full Text] [Related]
11. RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.
Takahashi K; Shigeyasu K; Kondo Y; Gotoh K; Yano S; Umeda Y; Inokuchi T; Xu C; Yoshida K; Umeda H; Takahashi T; Takeda S; Yoshida R; Teraishi F; Kishimoto H; Mori Y; Noma K; Okugawa Y; Hiraoka S; Michiue H; Tazawa H; Matsushita O; Goel A; Fujiwara T
J Crohns Colitis; 2023 May; 17(5):754-766. PubMed ID: 36528792
[TBL] [Abstract][Full Text] [Related]
12. ADAR1 has an oncogenic function and can be a prognostic factor in cervical cancer.
Nakamura K; Shigeyasu K; Okamoto K; Matsuoka H; Masuyama H
Sci Rep; 2023 Mar; 13(1):4720. PubMed ID: 36959226
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
Liu Y; Wolff KC; Jacobs BL; Samuel CE
Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
[TBL] [Abstract][Full Text] [Related]
14. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR.
Toth AM; Li Z; Cattaneo R; Samuel CE
J Biol Chem; 2009 Oct; 284(43):29350-6. PubMed ID: 19710021
[TBL] [Abstract][Full Text] [Related]
15. RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells.
Omata Y; Okawa M; Haraguchi M; Tsuruta A; Matsunaga N; Koyanagi S; Ohdo S
J Biol Chem; 2022 Aug; 298(8):102184. PubMed ID: 35753353
[TBL] [Abstract][Full Text] [Related]
16. Defining the functions of adenosine-to-inosine RNA editing through hematology.
Heraud-Farlow JE; Chalk AM; Walkley CR
Curr Opin Hematol; 2019 Jul; 26(4):241-248. PubMed ID: 31033705
[TBL] [Abstract][Full Text] [Related]
17. ADAR1-mediated 3' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response.
Yang CC; Chen YT; Chang YF; Liu H; Kuo YP; Shih CT; Liao WC; Chen HW; Tsai WS; Tan BC
Cell Death Dis; 2017 May; 8(5):e2833. PubMed ID: 28542129
[TBL] [Abstract][Full Text] [Related]
18. An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks.
Ramírez-Moya J; Miliotis C; Baker AR; Gregory RI; Slack FJ; Santisteban P
Mol Cancer; 2021 Sep; 20(1):115. PubMed ID: 34496885
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicle‑mediated RNA editing may underlie the heterogeneity and spread of hepatocellular carcinoma in human tissue and
Shibata C; Otsuka M; Shimizu T; Seimiya T; Kishikawa T; Aoki T; Fujishiro M
Oncol Rep; 2023 Nov; 50(5):. PubMed ID: 37732519
[TBL] [Abstract][Full Text] [Related]
20. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.
Sagredo EA; Blanco A; Sagredo AI; Pérez P; Sepúlveda-Hermosilla G; Morales F; Müller B; Verdugo R; Marcelain K; Harismendy O; Armisén R
Biol Res; 2018 Oct; 51(1):36. PubMed ID: 30290838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
